Glenmark Pharmaceuticals
Glenmark to market Crofelemer despite Napo nix
15 Dec 2011
Glenmark sells new drug licence to Sanofi for $50 mn
17 May 2011
In addition, Glenmark could receive potential success-based development, regulatory and commercial milestone payments of up to $613 million, subject to the drug getting past the remaining phases of human trials
US FDA approves Glenmark's corticosteroid
10 Aug 2010
Merck settles Zetia patent suit with Glenmark
11 May 2010
.webp)
